Atul Deodhar

79PUBLICATIONS
170CO-AUTHORS
PharmacogenomicsPhysiotherapyRheumatology and arthritisMolecular targetsClinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Oct 11, 2026
Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.

|Sep 03, 2026
Spondyloarthritis Research and Treatment Network Recommendations for the Referral of Adults With Chronic Back Pain and Suspected Axial Spondyloarthritis to a Rheumatologist.

|Aug 17, 2026
Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials.

|Aug 10, 2026
Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits.

|Jul 20, 2026
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety Up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

|Nov 27, 2025
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative.

Fabian Proft, Andre L Ribeiro, Shikha Singla

Pageof 14

Frequent Collaborators

15 joint publications

Phillip J Mease

10 joint publications

Denis Poddubnyy

10 joint publications

Lianne S Gensler

10 joint publications

Xenofon Baraliakos